Khan, A. Et Al. 2019. Anomalin attenuates LPS-induced acute lungs injury through inhibition of AP-1 signaling. INTERNATIONAL IMMUNOPHARMACOLOGY , vol.73 , 451-460.

Khan, A., Khan, S., Ali, H., Shah, K. U., Ali, H., Shehzad, O., ... ÖNDER, A.(2019). Anomalin attenuates LPS-induced acute lungs injury through inhibition of AP-1 signaling. INTERNATIONAL IMMUNOPHARMACOLOGY , vol.73, 451-460.

Khan, Ashrafullah Et Al. "Anomalin attenuates LPS-induced acute lungs injury through inhibition of AP-1 signaling," INTERNATIONAL IMMUNOPHARMACOLOGY , vol.73, 451-460, 2019

Khan, Ashrafullah Et Al. "Anomalin attenuates LPS-induced acute lungs injury through inhibition of AP-1 signaling." INTERNATIONAL IMMUNOPHARMACOLOGY , vol.73, pp.451-460, 2019

Khan, A. Et Al. (2019) . "Anomalin attenuates LPS-induced acute lungs injury through inhibition of AP-1 signaling." INTERNATIONAL IMMUNOPHARMACOLOGY , vol.73, pp.451-460.

@article{article, author={Ashrafullah Khan Et Al. }, title={Anomalin attenuates LPS-induced acute lungs injury through inhibition of AP-1 signaling}, journal={INTERNATIONAL IMMUNOPHARMACOLOGY}, year=2019, pages={451-460} }